Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer. [electronic resource]
Producer: 20170202Description: 7809-21 p. digitalISSN:- 1423-0380
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Blood -- drug effects
- Blood Coagulation -- drug effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Cycle Checkpoints -- drug effects
- Cell Line
- Cisplatin -- administration & dosage
- Complement Activation -- drug effects
- Drug Carriers
- Drug Compounding
- Folic Acid -- administration & dosage
- Hemolysis -- drug effects
- Humans
- Leukocyte Count
- Lung Neoplasms -- drug therapy
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Nanoparticles -- administration & dosage
- Paclitaxel -- administration & dosage
- Polyesters -- administration & dosage
- Polyethylene Glycols -- administration & dosage
- Rabbits
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.